RecallDepth
Class II Terminated

Amlodipine Besylate Tablets, USP, 2.5 mg*, packaged in a)100-count (10 x 10) unit dose blisters per carton, NDC 51079-450-20 and b) 30-count tablets per dosage card in a carton, NDC 51079-450-63, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505; Packaged and Distributed By: UDL Laboratories, Inc., Rockford, IL 61103.

This recall has been terminated (originally issued August 31, 2016).

Company
Mylan Institutional, Inc. (D.B.A. Udl Laboratories)
Recall Initiated
September 17, 2013
Posted
August 31, 2016
Recall Number
D-1466-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 9,156 cartons; b) 521,310 cartons
Firm Location
Rockford, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Distribution

Nationwide, Puerto Rico and Guam

Lot / Code Info

Lot #: a) 3039792, Exp 04/14; 3037880, Exp 01/14; 3043938, Exp 07/14; b) 3036811, Exp 10/13; 3037514, Exp 01/14; 3039975, Exp 04/14; 3042583, Exp 07/14

More recalls by Mylan Institutional, Inc. (D.B.A. Udl Laboratories)

View all recalls by this company →

Other recent Class II Drug recalls